buserelin (receptal) Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Buserelin, sold under the brand name Suprefact among others, is a medication which is used primarily in the treatment of prostate cancer and endometriosis. It is also used for other indications such as the treatment of premenopausal breast cancer, uterine fibroids, and early puberty, in assisted reproduction for female infertility, and as a part of transgender hormone therapy. In addition, buserelin is used in veterinary medicine. The medication is typically used as a nasal spray three times per day, but is also available for use as a solution or implant for injection into fat.   Wikipedia

Chemistry

  • SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1
  • InChIKey: CUWODFFVMXJOKD-UVLQAERKSA-N
  • Mol. Mass: 1239.45
  • ALogP: Missing data
  • ChEMBL Molecules:
    buserelin  
    buserelin acetate  
More Chemistry

Pharmacology

Alternative names

buserelin | buserelin acetate | (des-gly10,d-ser(tbu)6,pro-nhet9)-lhrh | d-ser(tbu)6ea10lhrh | etilamide | receptal | suprecur | suprefact

Organizations (33)

Research & Development (33)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (1)


 

Anovulation

Experimental Indications - Clinical Trial Phases 1-4 (10)


 

Breast Neoplasms (Phase 2)

Fertilization in Vitro (Phase 4)

Infertility (Phase 4)

Neoplasm Metastasis (Phase 3)

Osteoporosis (Phase 3)

Ovarian Diseases (Phase 4)

Ovulation Induction (Phase 4)

Pregnancy (Phase 4)

Prostatic Neoplasms (Phase 3)

Prostatic Neoplasms, Castration-Resistant (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 23
  • # of Trial Organizations: 33

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue